How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.
Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...
Architecture delivery. The stories were vehicles; the real payload was a way of organizing experience into causal, moral, and ...
As AI transforms education, we must redefine intelligence beyond biological limits and embrace cognitive functions across ...
The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...
The loop takes agentic AI a step further, by authorizing a swarm of agents to work continuously in the background, endlessly.
Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...
Alongside this rapid progress, an equally ambitious effort has emerged to construct ethical frameworks for intelligent ...
Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...